47 results
8-K/A
EX-3.1
GRNA
GreenLight Biosciences Inc
28 Jul 23
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
9:02am
or activity to improve the public health and wellbeing of people and the environment by, among other things, engineering, developing … and commercializing biological products that can reduce chemicals in the environment and promote health through delivery of high quality, affordable solutions
8-K
EX-3.1
GRNA
GreenLight Biosciences Inc
24 Jul 23
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
9:58am
or activity to improve the public health and wellbeing of people and the environment by, among other things, engineering, developing … and commercializing biological products that can reduce chemicals in the environment and promote health through delivery of high quality, affordable solutions
SC 14D9/A
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation (amended)
4:05pm
and industry trends, future short- and long-term growth prospects, the current and expected financing environment (including the financing challenges … environment in which the Company operates, including economic and market conditions and competitive considerations. The Special Committee considered
SC 14D9
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
and industry trends, future short- and long-term growth prospects, the current and expected financing environment (including the financing challenges associated … environment in which the Company operates, including economic and market conditions and competitive considerations. The Special Committee considered the Offer
SC 14D9
EX-99
GRNA
GreenLight Biosciences Inc
21 Jun 23
Tender offer solicitation
9:27am
share. The price of $0.30 per share still represents an approximate 50% premium to today’s stock price (1) Deteriorating Market Environment for DeSPAC … ) GRNA’s stock is down over 95% from its DeSPAC price of $10.00 per share Macro Economic Environment Distress Quantitative tightening coupled
SC TO-T
EX-99
mblghwymq 6fx2o8
21 Jun 23
Third party tender offer statement
9:23am
8-K
EX-2.1
i37mgyzkvmv19s0
30 May 23
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by
7:11am
424B3
t9km0 ocupkeqena37ba
9 Nov 22
Prospectus supplement
5:27pm
424B3
63h3eogmn 2z2
6 Oct 22
Prospectus supplement
5:15pm
8-K
EX-99.1
s6hmf8tosul2qz
15 Aug 22
GreenLight Biosciences Announces Second Quarter 2022 Financial
6:07pm
424B3
4bh4dmw4p3kcgiq42
7 Apr 22
Prospectus supplement
4:02pm
POS AM
5852v jlm37
5 Apr 22
Prospectus update (post-effective amendment)
5:18pm
424B3
2fbopl a82hmyq3fd1d1
15 Feb 22
Prospectus supplement
1:38pm